Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.435    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.03b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB 3rd Quarter Separate Results

10 Nov 2016 07:00

RNS Number : 7866O
Commercial Intnl Bank (Egypt) SAE
10 November 2016
 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

September 30, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL POSITION

As of September 30, 2016

Amounts in EGP Thousands

Note

September 30, 2016

 

September 30, 2015

 

Assets

Cash and balances with central bank

15

 12,434,973

 9,848,954

Due from banks

16

 41,177,611

 21,002,305

Treasury bills and other governmental notes

17

 21,613,272

 22,130,170

Trading financial assets

18

 3,661,744

 5,848,377

Loans and advances to banks, net

19

 77,334

 38,443

Loans and advances to customers, net

20

 61,157,352

 57,172,705

Derivative financial instruments

21

 66,018

 80,995

Financial investments

- Available for sale

22

 29,879,804

 46,289,075

- Held to maturity

22

 26,312,316

 9,261,220

Investments in associates

23

 11,100

 12,600

Non-current assets held for sale

42

 428,011

 503,066

Other assets

24

 4,366,371

 4,799,937

Goodwill

41

 177,280

 209,842

Intangible assets

41

 531,683

 629,340

Deferred tax assets (Liabilities)

32

 258,066

 258,157

Property, plant and equipment

25

 1,235,121

 1,107,905

Total assets

 203,388,056

 179,193,091

Liabilities and equity

Liabilities

Due to banks

26

 477,662

 1,600,769

Due to customers

27

 178,170,297

 155,369,922

Derivative financial instruments

21

 65,622

 145,735

Current tax liabilities

 1,452,955

 1,949,694

Other liabilities

29

 2,888,038

 2,622,269

Long term loans

28

 147,628

 131,328

Other provisions

30

 1,037,363

 861,761

Total liabilities

 184,239,565

 162,681,478

Equity

Issued and paid up capital

31

 11,538,660

 11,470,603

Reserves

34

 2,874,876

 152,144

Reserve for employee stock ownership plan (ESOP)

 302,441

 248,148

Total equity

 14,715,977

 11,870,895

Net profit for the period/year

 4,432,514

 4,640,718

Total equity and net profit for the period/year

 19,148,491

 16,511,613

Total liabilities and equity

 203,388,056

 179,193,091

INCOME STATEMENT

As of September 30, 2016

Amounts in EGP Thousands

Note

September 30, 2016

 

September 30, 2015

 

Interest and similar income

13,486,623

 10,739,385

Interest and similar expense

(6,420,760)

 (4,831,979)

Net interest income

6

7,065,863

 5,907,406

Fee and commission income

 1,385,726

 1,383,052

Fee and commission expense

 (279,399)

 (199,589)

Net fee and commission income

7

 1,106,327

 1,183,463

Dividend income

8

 32,019

 33,769

Net trading income

9

 696,412

 439,725

Profits on financial investments

22

 44,236

 158,337

Administrative expenses

10

 (1,793,713)

 (1,412,574)

Other operating (expenses) income

11

 (557,683)

 (334,540)

Goodwill amortization

41

 (32,561)

 -

Intangible assets amortization

41

 (97,656)

 -

Impairment charge for credit losses

12

 (577,684)

 (1,120,280)

Profit before income tax

5,885,560

 

4,855,306

Income tax expense

13

 (1,452,955)

 (1,430,088)

Deferred tax assets (Liabilities)

32 & 13

 (91)

 85,687

Net profit for the period

 4,432,514

 3,510,905

Earnings per share

14

3.40

2.69

Basic

3.35

2.65

Diluted

 

CASH FLOW STATEMENT

As of September 30, 2016

 

 

 

Amounts in EGP Thousands

 

September 30, 2016

September 30, 2015

Cash flow from operating activities

Profit before income tax

5,885,560

4,855,306

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

205,146

163,728

Impairment charge for credit losses

577,684

1,120,280

Other provisions charges

165,575

113,569

Trading financial investments revaluation differences

50,748

352,177

Available for sale and held to maturity investments exchange revaluation differences

(263,567)

(96,639)

Goodwill amortization

32,561

-

Intangible assets amortization

97,656

-

Financial investments impairment charge

57,328

(28,083)

Utilization of other provisions

(2,822)

(4,649)

Other provisions no longer used

(47,405)

-

Exchange differences of other provisions

60,254

19,004

Profits from selling property, plant and equipment

(575)

(1,127)

Profits from selling financial investments

(10,935)

(161,897)

Profits from selling associates

(84,948)

-

Shares based payments

145,981

127,827

Operating profits before changes in operating assets and liabilities

6,868,241

6,459,496

Net decrease (increase) in assets and liabilities

Due from banks

Treasury bills and other governmental notes

Trading financial assets

Derivative financial instruments

Loans and advances to banks and customers

Other assets

Due to banks

Due to customers

Income tax obligations paid

Other liabilities

Net cash provided from operating activities

 

 

(19,125,704)

(531,505)

2,135,885

(65,136)

(4,601,222)

541,151

(1,123,107)

22,800,375

(1,949,694)

265,769

5,215,053

 

 (7,329,312)

 2,335,423

 (2,978,385)

 (106,398)

 (9,479,160)

 (315,794)

 (201,313)

 32,133,953

 (1,814,609)

 (21,732)

 18,682,169

Cash flow from investing activities

Proceeds from selling subsidiary and associates

161,503

-

Payment for purchases of property, plant, equipment and branches constructions

(439,372)

(233,948)

Proceeds from redemption of held to maturity financial investments

4,094

3,917,715

Payment for purchases of held to maturity financial investments

(2,367,123)

(4,019,548)

Payment for purchases of available for sale financial investments

(3,024,361)

(21,237,674)

Proceeds from selling available for sale financial investments

4,416,515

4,698,647

Proceeds (payments) from real estate investments

-

884,094

Net cash used in investing activities

(1,248,744)

(15,990,714)

 

Cash flow from financing activities

Increase (decrease) in long term loans

16,300

(74,422)

Dividend paid

(1,463,450)

(1,563,646)

Capital increase

68,057

94,748

Net cash used in financing activities

(1,379,093)

 

(1,543,320)

Net increase (decrease) in cash and cash equivalent during the period

2,587,216

1,148,135

Beginning balance of cash and cash equivalent

12,622,530

14,811,360

Cash and cash equivalent at the end of the period

15,209,746

15,959,495

Cash and cash equivalent comprise:

Cash and balances with central bank

12,434,973

9,230,657

Due from banks

41,177,611

15,690,424

Treasury bills and other governmental notes

21,613,272

28,542,497

Obligatory reserve balance with CBE

(9,846,334)

(7,032,352)

Due from banks with maturities more than three months

(33,025,910)

(10,696,968)

Treasury bills with maturity more than three months

(17,143,866)

(19,774,763)

 

Total cash and cash equivalent

15,209,746

 

15,959,495

 

 

 

 

 

 

 

 

 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

 

Separate statement of changes in shareholders' equity for the period ended September 30, 2015

Sep. 30, 2015

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the year / period

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

9,081,734

621,084

1,850,648

28,108

(593,237)

1,991

3,647,530

177,766

14,815,624

Capital increase

94,748

-

-

-

-

-

-

-

94,748

Transferred to reserves

-

182,271

1,961,998

2,106

-

-

(2,083,362)

(63,013)

-

Dividend paid

-

-

-

-

-

-

(1,563,646)

-

(1,563,646)

Net profit for the period

-

-

-

-

-

-

3,510,905

-

3,510,905

Net unrealized gain/(loss) on AFS

-

-

-

-

(1,200,599)

-

-

-

(1,200,599)

Transferred (from) to bank risk reserve

-

-

-

-

-

522

(522)

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

127,827

127,827

Balance at the end of the period

9,176,482

803,355

3,812,646

30,214

(1,793,836)

2,513

3,510,905

242,580

15,784,859

 

 

Separate statement of changes in shareholders' equity for the period ended September 30, 2016

Sep. 30, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the year / period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

4,640,718

248,148

16,511,613

 

Capital increase

68,057

-

-

-

-

-

-

-

68,057

 

Transferred to reserves

-

232,008

3,035,878

564

-

-

(3,176,762)

(91,688)

-

 

Dividend paid

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

 

Net profit for the period

-

-

-

-

-

-

4,432,514

-

4,432,514

 

Net unrealised gain/(loss) on AFS

-

-

-

-

(546,224)

-

-

-

(546,224)

 

Transferred (from) to bank risk reserve

-

-

-

-

-

506

(506)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

145,981

145,981

 

Balance at the end of the period

11,538,660

1,035,363

4,554,403

30,778

(2,748,687)

3,019

4,432,514

302,441

19,148,491

 

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document;

http://www.rns-pdf.londonstockexchange.com/rns/7866O_-2016-11-9.pdf

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTUKRNRNVAARAA
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.